AlphaFold predicted structure
OTULIN · Q96BN8

Mean pLDDT
83.8/ 100
Confident
352 residues
Confidence breakdown
- Very high(≥ 90)72%
- Confident(70–90)3%
- Low(50–70)7%
- Very low(< 50)18%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
OTU deubiquitinase with linear linkage specificity
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Autoinflammatory disorders
BIALLELIC, autosomal or pseudoautosomalCOVID-19 research
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalGastrointestinal epithelial barrier disorders
BIALLELIC, autosomal or pseudoautosomalInfantile enterocolitis & monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalPeriodic fever syndromes
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BOTH monoallelic and biallelic, autosomal or pseudoautosomalSevere insulin resistance and lipodystrophy syndromes
BIALLELIC, autosomal or pseudoautosomal+2 more panels — install the extension to see the full list inline on any page.
autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive
immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection
autoinflammation, panniculitis, and dermatosis syndrome
craniometaphyseal dysplasia
allergic rhinitis
chondrocalcinosis 2
autoinflammatory syndrome
Eczematoid dermatitis
asthma
autoinflammation, panniculitis, and dermatosis syndrome, autosomal dominant
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Ubiquitin thioesterase otulin
Deubiquitinase that specifically removes linear ('Met-1'-linked) polyubiquitin chains to substrates and acts as a regulator of angiogenesis and innate immune response (PubMed:23708998, PubMed:23746843, PubMed:23806334, PubMed:23827681, PubMed:24726323, PubMed:24726327, PubMed:26997266, PubMed:27523608, PubMed:27559085, PubMed:28919039, PubMed:30804083, PubMed:35170849, PubMed:35587511, PubMed:38630025, PubMed:38652464). Required during angiogenesis, craniofacial and neuronal development by regulating the canonical Wnt signaling together with the LUBAC complex (PubMed:23708998). Acts as a negative regulator of NF-kappa-B by regulating the activity of the LUBAC complex (PubMed:23746843, PubMed:23806334). OTULIN function is mainly restricted to homeostasis of the LUBAC complex: acts by removing 'Met-1'-linked autoubiquitination of the LUBAC complex, thereby preventing inactivation of the LUBAC complex (PubMed:26670046). Acts as a key negative regulator of inflammation by restricting spontaneous inflammation and maintaining immune homeostasis (PubMed:27523608). In myeloid cell, required to prevent unwarranted secretion of cytokines leading to inflammation and autoimmunity by restricting linear polyubiquitin formation (PubMed:27523608). Plays a role in innate immune response by restricting linear polyubiquitin formation on LUBAC complex in response to NOD2 stimulation, probably to limit NOD2-dependent pro-inflammatory signaling (PubMed:23806334)
OTULIN · Q96BN8

Mean pLDDT
83.8/ 100
Confident
352 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0